Analogic, VisEn Medical ink development & manufacturing agreement

Analogic Corp. this week entered into an agreement to develop and manufacture fluorescence molecular tomography (FMT) imaging systems for VisEn Medical of Woburn, MA.

FMT is part of the rapidly emerging field of molecular imaging which enables molecular-level visualization of early-stage disease states and processes. FMT systems are being developed initially for drug development and research applications.

Additional terms of the agreement were not disclosed.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.